News
This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates ...
This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells.
This research indicates that Doxorubicin (Dox)-resistant TNBC cells exhibit increased glycolysis and ATP generation compared ...
One of the biggest obstacles in cancer treatment is drug resistance in cancer cells. Conventional efforts have focused on ...
A new randomized, placebo-controlled clinical trial has found that short-term supplementation with CBD/CBDA-rich hemp oil appears safe and well-tolerated in dogs receiving chemotherapy for lymphoma.
Dr Zain Hasan is an anesthesiologist based out of California. He says everything from pain killers to chemo drugs could ...
Read the side effects of Doxorubicin as described in the medical literature. In case of any doubt consult your doctor or pharmacist.
Accord are one of the first to market generic doxorubicin pegylated liposomal 2mg/ml concentrate for solution for infusion in the UK and Europe LONDON, Aug. 8, 2022 /PRNewswire/ -- ...
A study conducted in rats suggests that taking vitamin C may help to counteract the muscle atrophy that is a common side effect of the chemotherapy drug doxorubicin.
The combination of doxorubicin and trabectedin (Yondelis) continued to show encouraging activity as first-line treatment of patients with metastatic or unresectable leiomyosarcoma (LMS), according ...
The combination of apatinib and pegylated liposomal doxorubicin improved the progression-free survival for patients with platinum-resistant or refractory ovarian cancer in comparison to doxorubicin ...
Replacing gemcitabine (Gemzar) with pegylated liposomal doxorubicin in a standard platinum-based regimen improved survival in recurrent ovarian cancer, a phase III trial has shown.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results